Valuation: Senzime AB

Market Cap 579M 59.67M 52.37M 48.77M 44.85M 84.08M 5.7B 85.52M 226M 2.83B 224M 219M 9.77B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 579M 59.67M 52.37M 48.77M 44.85M 84.08M 5.7B 85.52M 226M 2.83B 224M 219M 9.77B EV / Sales 2026 *
4.53x
EV / Sales 2027 * 2.84x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day-0.68%
1 week-6.28%
Current month-15.59%
1 month-14.50%
3 months-19.67%
6 months-27.62%
Current year-32.31%
1 week 3.54
Extreme 3.545
3.96
1 month 3.54
Extreme 3.545
4.44
Current year 3.54
Extreme 3.545
6
1 year 3.54
Extreme 3.545
7.38
3 years 3.54
Extreme 3.545
9.6
5 years 2.6
Extreme 2.605
24.8
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap.
9/12/25 Sell

Director

15,000 0.0095%
9/12/25 Buy

Director

15,000 0.0095%
28/11/25 Buy

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-0.68%-6.28%-49.02%-24.87% 59.48M
+2.91%+7.92%-14.87%-4.59% 182B
+3.28%+5.58%-5.54%-1.56% 108B
+2.06%+5.06%+11.25%+70.67% 60.54B
-4.21%-6.07%+22.50%+49.01% 50.53B
+3.72%+7.09%-9.95%-41.23% 43.79B
+2.04%+3.68% - - 33.57B
+3.13%+1.22%-15.49%-42.85% 28.31B
+2.38%-5.64%+31.51%-7.24% 23.31B
+4.13%+7.47%+0.46%-1.07% 21.28B
Average +1.84%-1.06%-3.24%-0.42% 55.12B
Weighted average by Cap. +2.26%+0.78%-3.13%+4.91%

Financials

2026 *2027 *
Net sales 128M 13.17M 11.56M 10.76M 9.9M 18.56M 1.26B 18.88M 49.98M 624M 49.45M 48.38M 2.16B 204M 21.04M 18.47M 17.2M 15.82M 29.65M 2.01B 30.16M 79.85M 997M 78.99M 77.29M 3.44B
Net income -68.9M -7.11M -6.24M -5.81M -5.34M -10.01M -679M -10.19M -26.97M -337M -26.68M -26.1M -1.16B -36.8M -3.8M -3.33M -3.1M -2.85M -5.35M -363M -5.44M -14.4M -180M -14.25M -13.94M -621M
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
29/07/26 SEK 3.655 -0.68% 58,445
27/07/26 SEK 3.680 +2.22% 136,471
24/07/26 SEK 3.600 -2.70% 317,505
23/07/26 SEK 3.700 -6.21% 312,087
22/07/26 SEK 3.945 +1.15% 88,367

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock